Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CRISABOROLE vs ENSIFENTRINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CRISABOROLE vs ENSIFENTRINE: Safety Overview

Metric CRISABOROLE ENSIFENTRINE
Total FAERS Reports 7,784 410
Deaths Reported 22 2
Death Rate 0.3% 0.5%
Hospitalizations 53 77
Average Patient Age 39.7 yrs 71.7 yrs
% Female Patients 65.9% 51.6%
FDA Approval Date Dec 14, 2016 Jun 26, 2024
Manufacturer Pfizer Laboratories Div Pfizer Inc Verona Pharma, Inc.
Route TOPICAL RESPIRATORY (INHALATION)
Marketing Status Prescription Prescription